Nephros Inc
(NEPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,371 | 1,322 | -3,262 | -2,360 | -1,933 |
| Depreciation Amortization | 536 | 480 | 151 | 131 | 179 |
| Accounts receivable | 12 | 820 | 1,006 | -832 | 283 |
| Other Working Capital | -478 | -1,187 | 1,087 | 465 | 355 |
| Other Operating Activity | 4,806 | -5,018 | -529 | 1,300 | -176 |
| Operating Cash Flow | $-2,495 | $-3,583 | $-1,547 | $-1,296 | $-1,292 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 3 | 47 | N/A | -30 |
| Purchase Sale Intangibles | N/A | N/A | -659 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -659 | 0 | 0 |
| Investing Cash Flow | $N/A | $3 | $-612 | $N/A | $-30 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 500 |
| Debt Issued | 1,572 | 2,800 | N/A | N/A | N/A |
| Debt Repayment | -3,250 | -1,300 | N/A | -500 | N/A |
| Common Stock Issued | 4,881 | 3,019 | 503 | 3,363 | 72 |
| Other Financing Activity | 0 | -399 | 0 | -140 | 0 |
| Financing Cash Flow | $3,203 | $4,120 | $503 | $2,723 | $572 |
| Exchange Rate Effect | -3 | -8 | 34 | 2 | -14 |
| Beginning Cash Position | 579 | 47 | 1,669 | 240 | 1,004 |
| End Cash Position | 1,284 | 579 | 47 | 1,669 | 240 |
| Net Cash Flow | $705 | $532 | $-1,622 | $1,429 | $-764 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,495 | -3,583 | -1,547 | -1,296 | -1,292 |
| Capital Expenditure | N/A | N/A | -8 | N/A | -30 |
| Free Cash Flow | -2,495 | -3,583 | -1,555 | -1,296 | -1,322 |